Vera E van der Noord (V E van der Noord, Vera van der Noord)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Breast Cancer Cells

Bioinformatics Analysis

Dna Methylation

Endoplasmic Reticulum Stress

Top Venues

Breast cancer research and treatment

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Qiuyu Liu, Nasi Liu, Vera E van der Noord, Wanda van der Stel, Bob van de Water, Erik H J Danen, Sylvia E Le Dévédec
Differential response of luminal and basal breast cancer cells to acute and chronic hypoxia. Breast cancer research and treatment 198 (3) (2023)
Qiuyu Liu, Nasi Liu, Vera E van der Noord, Wanda van der Stel, Bob van de Water, Erik H J Danen, Sylvia E Le Dévédec
Differential response of luminal and basal breast cancer cells to acute and chronic hypoxia. Breast cancer research and treatment 198 (3) (2023)
Qiuyu Liu, Nasi Liu, Vera E van der Noord, Wanda van der Stel, Bob van de Water, Erik H J Danen, Sylvia E Le Dévédec
Differential response of luminal and basal breast cancer cells to acute and chronic hypoxia. Breast cancer research and treatment (2023)
Vera E van der Noord, Bob van de Water, Sylvia E Le Dévédec
Targeting the Heterogeneous Genomic Landscape in Triple-Negative Breast Cancer through Inhibitors of the Transcriptional Machinery. Cancers 14 (18) (2022)
Qiuyu Liu, Wanda van der Stel, Vera E van der Noord, Hanneke Leegwater, Bircan Coban, Kim Elbertse, Joannes T M Pruijs, Olivier J M Béquignon, Gerard van Westen, Sylvia E Le Dévédec, Erik H J Danen
Hypoxia Triggers TAZ Phosphorylation in Basal A Triple Negative Breast Cancer Cells. International journal of molecular sciences 23 (17) (2022)
S J A M Santegoets, A F de Groot, E M Dijkgraaf, A M Carnaz Simões, Vera E van der Noord, J J van Ham, M J P Welters, J R Kroep, S H van der Burg
The blood mMDSC to DC ratio is a sensitive and easy to assess independent predictive factor for epithelial ovarian cancer survival. Oncoimmunology 7 (8) (2018)